Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds
暂无分享,去创建一个
A. di Pietro | S. Døskeland | L. Herfindal | M. Kassack | J. Jose | G. Gausdal | P. Sonnet | C. Mullié | M. Le Borgne | M. Baitiche | G. Valdameri | Z. Bouaziz | Camille Desgrouas | N. Taudon | A. Bollacke | S. Issa | Jacques Gentili | A. Gratz
[1] Shu Liu,et al. Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2 , 2013, BMC Pharmacology and Toxicology.
[2] G. Zeng,et al. A New Cytotoxic Carbazole Alkaloid and Two New Other Alkaloids from Clausena excavata , 2013, Chemistry & biodiversity.
[3] Jin-Ying Tian,et al. Bioactive carbazole alkaloids from Murraya koenigii (L.) Spreng. , 2013, Fitoterapia.
[4] K. L. Le Roch,et al. Recent advances in malaria drug discovery. , 2013, Bioorganic & medicinal chemistry letters.
[5] E. Débiton,et al. Synthesis and Biological Activities of 4‐Substituted Pyrrolo[2,3‐a]carbazole Pim Kinase Inhibitors. , 2013 .
[6] J. Settleman,et al. Noncovalent wild-type-sparing inhibitors of EGFR T790M. , 2013, Cancer discovery.
[7] P. Shanmughavel,et al. Synthesis of hetero annulated carbazoles: exploration of in vitro cytotoxicity and molecular docking studies , 2013 .
[8] B. Bandgar,et al. Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents. , 2012, Bioorganic & medicinal chemistry letters.
[9] A. W. Schmidt,et al. Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids , 2012 .
[10] E. Débiton,et al. Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-a]carbazole derivatives. , 2012, Bioorganic & medicinal chemistry letters.
[11] F. Totzke,et al. Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors. , 2012, Bioorganic & medicinal chemistry.
[12] S. Døskeland,et al. Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription , 2011, Cell Death and Disease.
[13] C. Vairappan,et al. Biological Activity of Carbazole Alkaloids and Essential Oil of Murraya koenigii Against Antibiotic Resistant Microbes and Cancer Cell Lines , 2011, Molecules.
[14] S. Bates,et al. The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan. , 2011, European journal of cancer.
[15] C. Nguyen,et al. Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2. , 2010, Cancer research.
[16] C. Bailly,et al. Synthesis and biological activities of new furo[3,4-b]carbazoles: potential topoisomerase II inhibitors. , 2010, European journal of medicinal chemistry.
[17] I. Kassab,et al. Synthesis and antiproliferative activity of oxazinocarbazole and N,N-bis(carbazolylmethyl)amine derivatives. , 2010, European journal of medicinal chemistry.
[18] Cheng‐He Zhou,et al. Synthesis, antibacterial and antifungal activities of some carbazole derivatives. , 2010, Bioorganic & medicinal chemistry letters.
[19] C. Götz,et al. A CE‐based assay for human protein kinase CK2 activity measurement and inhibitor screening , 2010, Electrophoresis.
[20] I. Kassab,et al. Mannich Reaction of 5‐Hydroxy‐β‐carboline. Application to the Synthesis of Novel Oxazinopyrimidocarboline Derivatives. , 2009 .
[21] I. Kassab,et al. Mannich Reaction of 5-Hydroxy-b-carboline. Application to the Synthesis of Novel Oxazinopyrimidocarboline Derivatives , 2008 .
[22] B. Fenet,et al. Regioselectivity in the 1,3‐Dipolar Cycloaddition Reactions of Nitrile Oxides and Organic Azides with Bromocarbazole‐1,4‐diones. , 2007 .
[23] S. Bates,et al. Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure , 2007, Molecular Cancer Therapeutics.
[24] Joachim Jose,et al. Synthesis and Biological Evaluation of 3-(Substituted-benzylidene)-1,3-dihydro-indolin Derivatives as Human Protein Kinase CK2 and p60c-Src Tyrosine Kinase Inhibitors , 2007 .
[25] B. Fenet,et al. Regioselectivity in the 1,3-Dipolar Cycloaddition Reactions of Nitrile Oxides and Organic Azides with Bromocarbazole-1,4-diones , 2007 .
[26] S. Olgen,et al. Synthesis and biological evaluation of 3-(substituted-benzylidene)-1,3-dihydro-indolin derivatives as human protein kinase CK2 and p60(c-Src) tyrosine kinase inhibitors. , 2007, Biological & pharmaceutical bulletin.
[27] Clinical,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard , 2006 .
[28] Ø. Bruserud,et al. Animal models of acute myelogenous leukaemia – development, application and future perspectives , 2005, Leukemia.
[29] Z. Bouaziz,et al. Synthesis and Diels—Alder Reactivity of ortho-Carbazolequinones. , 2005 .
[30] W. Frank,et al. Synthesis, antitumour activity and structure-activity relationships of 5H-benzo[b]carbazoles. , 2005, Bioorganic & medicinal chemistry.
[31] O. Issinger,et al. Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. , 2003, Journal of molecular biology.
[32] B. Fenet,et al. Synthesis of Carbazolequinone Derivatives as Inhibitors ofToxoplasma gondii Purine Nucleoside Phosphorylase , 2002 .
[33] Christine Farenc,et al. Pk-fit: A Pharmacokinetic/Pharmacodynamic and Statistical Data Analysis Software , 2000, Comput. Biomed. Res..
[34] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[35] Z. Bouaziz,et al. Regiospecific Hetero Diels‐Alder Synthesis of Pyrido(2,3‐b)‐ and Pyrido(3,2‐b)carbazole‐5,11‐diones. , 1997 .
[36] Z. Bouaziz,et al. Regiospecific hetero diels-alder synthesis of pyrido[2,3-b]- and pyrido[3,2-b]carbazole-5,11-diones , 1997 .
[37] C. Teng,et al. Carbazole alkaloids from Clausena excavata and their biological activity. , 1996, Phytochemistry.
[38] M. Lanotte,et al. Conditions controlling long-term proliferation of Brown Norway rat promyelocytic leukemia in vitro: primary growth stimulation by microenvironment and establishment of an autonomous Brown Norway 'leukemic stem cell line'. , 1983, Leukemia research.
[39] J. Haynes,et al. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique , 1979, Antimicrobial Agents and Chemotherapy.